CAR-T | opacc

CAR T cell therapy for pediatric brain cancer warrants further study

Researchers at Texas Children’s Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s...

CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I clinical trial

Researchers at Texas Children’s Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s...

CAR T cell therapy for pediatric patients: What parents should know

CAR T cell therapy is a type of immunotherapy that modifies T cells, so they can detect and fight cancer cells. This therapy is...

Combining CAR-T cells and inhibitor drugs for high-risk neuroblastoma

Roberto Chiarle, MD, at Boston Children's Hospital and his colleagues now report a way to make CAR-T cell therapy work better in...

Beyond chemotherapy: Navigating the promise and perils of CAR-T therapy in pediatric cancer

Upon hearing the phrase ‘cancer treatment’, the first word that can typically spring to mind is chemotherapy – a primary therapy which...

Rethinking the Development of CAR T-Cell Products for Pediatric Cancer

In a commentary published in the Journal of Clinical Oncology, Claudia Rossig, MD, of the department of pediatric hematology and oncology...

Promising target for CAR T cells helps cancer trick the immune system

Scientists at St. Jude Children’s Research Hospital showed that GRP78 is a promising but complex target for CAR T–cell immunotherapy...

NIH researchers develop approach that could help supercharge T-cell therapies against solid tumors

Researchers at the National Institutes of Health have developed a way to potentially increase the effectiveness of T cell–based...

Solving the Mystery of Long-Lasting Cancer Treatment – Scientists Reveal New Insights

Researchers from UCL, Great Ormond Street Hospital, and the Wellcome Sanger Institute have unveiled findings that shed light on why...

Advanced immunotherapy treatment may hold promise for children with brain cancer

WEHI researchers have found promise in treating DIPG with an innovative new immunotherapy treatment, called CAR T therapy. Read more:...

1

FDA Grants Orphan Drug Designation to Opaganib in Neuroblastoma

After my daughter's cancer, I wanted to control her entire life. Then she went to college.

When Childhood Cancer Survivors Face Sexual Challenges

Early interventions may improve long-term academic achievement in young childhood brain tumor survivors

Immunotherapy for children with primary liver carcinomas: Research offers new hope

Pediatric psychologist explains how to support your child's development after a cancer diagnosis

Adult Survivors of Childhood Cancer Have High Prevalence of Chronic Pain

Spontaneous Remission in Childhood Cancer Rare but Fleeting

First successful treatment of pediatric high-risk refractory neuroblastoma with PARP inhibition

Researchers identify malignant cells responsible for relapse in high-risk neuroblastoma